Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway

Xuehui Wang,Changle Ji,Jiashu Hu,Xiaochong Deng,Wenfang Zheng,Yunhe Yu,Kaiyao Hua,Xiqian Zhou,Lin Fang

DOI: https://doi.org/10.1186/s13046-021-02160-w

2021-11-16

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology

What problem does this paper attempt to address?

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Wenxing Chen,Yanhong Pan,Siliang Wang,Yuping Liu,Guangying Chen,Liang Zhou,Chao Zhang,Wenting Ni,Aiyun Wang,Yin Lu,Shile Huang

DOI: https://doi.org/10.1186/s12885-019-5458-y

IF: 4.638

2019-01-01

BMC Cancer

Abstract:Following publication of the original article [1], the author noticed the following errors in the article.
Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Kun Qiao,Shipeng Ning,Lin Wan,Hao Wu,Qin Wang,Xingda Zhang,Shouping Xu,Da Pang

DOI: https://doi.org/10.1186/s13046-020-01645-4

2020-08-11

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Yan Chen,Zhonghu Li,Mengyun Zhang,Bo Wang,Jiaxin Ye,Yang Zhang,Di Tang,Dandan Ma,Weidong Jin,Xiaowu Li,Shuguang Wang

DOI: https://doi.org/10.1186/s13046-021-01902-0

2021-04-16

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation

Yan Gu,Yanrong Chen,Lai Wei,Shuang Wu,Kaicheng Shen,Chengxiang Liu,Yan Dong,Yang Zhao,Yue Zhang,Chi Zhang,Wenling Zheng,Jiangyi He,Yunlong Wang,Yifei Li,Xiaoxin Zhao,Hongwei Wang,Jun Tan,Liting Wang,Qi Zhou,Ganfeng Xie,Houjie Liang,Juanjuan Ou

DOI: https://doi.org/10.1038/s41467-023-37521-w

IF: 16.6

2023-04-05

Nature Communications

Abstract:Nature Communications, Published online: 04 April 2023; doi:10.1038/s41467-023-37521-w Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation

multidisciplinary sciences
Correction to: Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis

Yao Yao,Xinyuan Chen,Hong Yang,Wei Chen,Yichun Qian,Zhongyi Yan,Tian Liao,Weiping Yao,Wenlan Wu,Tonghua Yu,Yun Chen,Yuan Zhang

DOI: https://doi.org/10.1186/s13046-020-01560-8

IF: 12.658

2020-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:In the original publication of this manuscript [1], the Fig. 6a invasion si-hsa_circ_0058124_2# group (row 2 right and row 3 right) and Fig. 9c TPC-1 clone formation assay control group (row 1 left) were misplaced and need to be revised. The updated figures are shown below.
Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Cheng-Cao Sun,Wei Zhu,Shu-Jun Li,Wei Hu,Jian Zhang,Yue Zhuo,Han Zhang,Juan Wang,Yu Zhang,Shao-Xin Huang,Qi-Qiang He,De-Jia Li

DOI: https://doi.org/10.1186/s13073-021-00834-w

IF: 15.266

2021-02-11

Genome Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

genetics & heredity
Correction to: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

Dan Jin,Jiwei Guo,Yan Wu,Jing Du,Lijuan Yang,Xiaohong Wang,Weihua Di,Baoguang Hu,Jiajia An,Lingqun Kong,Lei Pan,Guoming Su

DOI: https://doi.org/10.1186/s13045-020-00942-x

2020-08-03

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,hematology
Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2

Zhenming Jiang,Yuxi Zhang,Xi Chen,Pingeng Wu,Dong Chen

DOI: https://doi.org/10.1186/s12935-021-01945-5

IF: 6.429

2021-04-26

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Publisher Correction: Intercellular Interaction Dictates Cancer Cell Ferroptosis Via NF2–YAP Signalling

Jiao Wu,Alexander M. Minikes,Minghui Gao,Huijie Bian,Yong Li,Brent R. Stockwell,Zhi-Nan Chen,Xuejun Jiang

DOI: https://doi.org/10.1038/s41586-019-1480-0

IF: 64.8

2019-01-01

Nature

Abstract:An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Corrigendum to 'inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer' [ebiomedicine 31 (2018) 276-286].

Tao Zhang,Jingjie Li,Xiaojun Ma,Yang,Wei Sun,Wangrui Jin,Lei Wang,Yuan He,Feifei Yang,Zhengfang Yi,Yingqi Hua,Mingyao Liu,Yihua Chen,Zhengdong Cai

DOI: https://doi.org/10.1016/j.ebiom.2020.102629

IF: 11.205

2020-01-01

EBioMedicine

Abstract:The published version of this article contained an error in Fig. 2c and f, the corrected Fig. 2 is included below, the authors declare that the corrections do not change the results or conclusions of this paper and apologize for any inconvenience this may have caused.
Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Jiajie Hou,He Zhang,Jun Liu,Zhenjun Zhao,Jianye Wang,Zhike Lu,Bian Hu,Jiankui Zhou,Zhicong Zhao,Mingxuan Feng,Haiyan Zhang,Bin Shen,Xingxu Huang,Beicheng Sun,Mark J. Smyth,Chuan He,Qiang Xia

DOI: https://doi.org/10.1186/s12943-020-01257-8

IF: 37.3

2020-09-04

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction: Upregulation of SNX5 Predicts Poor Prognosis and Promotes Hepatocellular Carcinoma Progression by Modulating the EGFR-ERK1/2 Signaling Pathway

Zhou, Qingqing,Huang, Tingting,Jiang, Zhiyuan,Ge, Chao,Chen, Xiaoxia,Zhang, Lili,Zhao, Fangyu,Zhu, Miaoxin,Chen, Taoyang,Cui, Ying,Li, Hong,Yao, Ming,Li, Jinjun,Tian, Hua

DOI: https://doi.org/10.1038/s41388-020-01440-7

IF: 8.756

2020-01-01

Oncogene

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma

Chenying Lu,Shiji Fang,Qiaoyou Weng,Xiuling Lv,Miaomiao Meng,Jinyu Zhu,Liyun Zheng,Yumin Hu,Yang Gao,Xulu Wu,Jianting Mao,Bufu Tang,Zhongwei Zhao,Li Huang,Jiansong Ji

DOI: https://doi.org/10.1186/s12964-020-00674-y

IF: 7.525

2020-10-22

Cell Communication and Signaling

Abstract:An amendment to this paper has been published and can be accessed via the original article.

cell biology
Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Kaiming Zhang,Peng Liu,Hailin Tang,Xiaoming Xie,Yanan Kong,Cailu Song,Xingsheng Qiu,Xiangsheng Xiao

DOI: https://doi.org/10.3389/fphar.2020.01107

IF: 5.6

2020-07-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2018.01248.].

pharmacology & pharmacy
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Fei Teng,Ju-Xiang Zhang,Qi-Meng Chang,Xu-Bo Wu,Wei-Guo Tang,Jian-Fa Wang,Jin-Feng Feng,Zi-Ping Zhang,Zhi-Qiu Hu

DOI: https://doi.org/10.1186/s13046-020-01780-y

2020-12-01

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Ming-Jenn Chen,De-Wei Wu,Yao-Chen Wang,Chi-Yi Chen,Huei Lee

DOI: https://doi.org/10.1038/s41598-020-74206-6

IF: 4.6

2020-10-23

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment

Jing Du,Weiwei Chen,Lijuan Yang,Juanjuan Dai,Jiwei Guo,Yan Wu,Kaikai Gong,Jian Zhang,Ning Yu,Zhen Xie,Sichuan Xi

DOI: https://doi.org/10.1038/s41598-020-74978-x

IF: 4.6

2020-10-22

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Correction: the Lipogenic LXR-SREBF1 Signaling Pathway Controls Cancer Cell DNA Repair and Apoptosis and is a Vulnerable Point of Malignant Tumors for Cancer Therapy.

Bo Yang,Bin Zhang,Zhifei Cao,Xingdong Xu,Zihe Huo,Pan Zhang,Shufen Xiang,Zhe Zhao,Chunping Lv,Mei Meng,Gaochuan Zhang,Liang Dong,Shucheng Shi,Lan Yang,Quansheng Zhou

DOI: https://doi.org/10.1038/s41418-020-0534-z

IF: 12.067

2020-01-01

Cell Death and Differentiation

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction to: Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence

Junming Bi,Hongwei Liu,Wei Dong,Weibin Xie,Qingqing He,Zijian Cai,Jian Huang,Tianxin Lin

DOI: https://doi.org/10.1186/s12943-020-01265-8

IF: 37.3

2020-10-12

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

Weiwei Sheng,Xiaoyang Shi,Yiheng Lin,Jingtong Tang,Chao Jia,Rongxian Cao,Jian Sun,Guosen Wang,Lei Zhou,Ming Dong

DOI: https://doi.org/10.1186/s13046-020-01663-2

2020-08-24

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation

Correction to: Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis

Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Correction to: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis

Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2

Publisher Correction: Intercellular Interaction Dictates Cancer Cell Ferroptosis Via NF2–YAP Signalling

Corrigendum to 'inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer' [ebiomedicine 31 (2018) 276-286].

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Correction: Upregulation of SNX5 Predicts Poor Prognosis and Promotes Hepatocellular Carcinoma Progression by Modulating the EGFR-ERK1/2 Signaling Pathway

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer

Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma

Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Author Correction: Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment

Correction: the Lipogenic LXR-SREBF1 Signaling Pathway Controls Cancer Cell DNA Repair and Apoptosis and is a Vulnerable Point of Malignant Tumors for Cancer Therapy.

Correction to: Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence

Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling